Logo image of EQS.PA

EQUASENS (EQS.PA) Stock Price, Quote, News and Overview

EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR

50.1  -0.6 (-1.18%)

EQS.PA Quote, Performance and Key Statistics

EQUASENS

EPA:EQS (5/23/2025, 7:00:00 PM)

50.1

-0.6 (-1.18%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High67.4
52 Week Low30.55
Market Cap760.02M
Shares15.17M
Float4.89M
Yearly Dividend1.25
Dividend Yield2.46%
PE20.96
Fwd PE17.16
Earnings (Next)07-31 2025-07-31
IPO10-20 2000-10-20


EQS.PA short term performance overview.The bars show the price performance of EQS.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

EQS.PA long term performance overview.The bars show the price performance of EQS.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of EQS.PA is 50.1 EUR. In the past month the price increased by 34.68%. In the past year, price decreased by -20.1%.

EQUASENS / EQS Daily stock chart

EQS.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
NXU.DE NEXUS AG 40.56 1.25B
COP.DE COMPUGROUP MEDICAL SE & CO K 42.46 1.19B
CONTX.OL CONTEXTVISION AB 27.33 380.66M
GPI.MI GPI SPA 2.88 298.93M
CGM.PA CEGEDIM SA N/A 160.74M
AGFB.BR AGFA-GEVAERT NV N/A 139.34M
AJ91.DE DOCCHECK AG 25.21 61.35M
ALMDT.PA MEDIAN TECHNOLOGIES N/A 41.90M
ALINS.PA INTRASENSE SAS N/A 14.29M
MLLAB.PA MEDIA LAB SPA N/A 5.21M

About EQS.PA

Company Profile

EQS logo image Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );

Company Info

EQUASENS

5 Allee de Saint-Cloud

Villers-les-Nancy GRAND EST FR

Employees: 1271

EQS Company Website

EQS Investor Relations

Phone: 33383159595

EQUASENS / EQS.PA FAQ

What is the stock price of EQUASENS today?

The current stock price of EQS.PA is 50.1 EUR. The price decreased by -1.18% in the last trading session.


What is the ticker symbol for EQUASENS stock?

The exchange symbol of EQUASENS is EQS and it is listed on the Euronext Paris - Matif exchange.


On which exchange is EQS.PA stock listed?

EQS.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for EQUASENS stock?

6 analysts have analysed EQS.PA and the average price target is 60.69 EUR. This implies a price increase of 21.14% is expected in the next year compared to the current price of 50.1. Check the EQUASENS stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EQUASENS worth?

EQUASENS (EQS.PA) has a market capitalization of 760.02M EUR. This makes EQS.PA a Small Cap stock.


How many employees does EQUASENS have?

EQUASENS (EQS.PA) currently has 1271 employees.


What are the support and resistance levels for EQUASENS (EQS.PA) stock?

EQUASENS (EQS.PA) has a support level at 39.85 and a resistance level at 53.57. Check the full technical report for a detailed analysis of EQS.PA support and resistance levels.


Is EQUASENS (EQS.PA) expected to grow?

The Revenue of EQUASENS (EQS.PA) is expected to grow by 9.26% in the next year. Check the estimates tab for more information on the EQS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EQUASENS (EQS.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EQUASENS (EQS.PA) stock pay dividends?

EQUASENS (EQS.PA) has a dividend yield of 2.46%. The yearly dividend amount is currently 1.25. Check the full fundamental report for a detailed analysis of EQS.PA dividend history, reliability and sustainability.


When does EQUASENS (EQS.PA) report earnings?

EQUASENS (EQS.PA) will report earnings on 2025-07-31.


What is the Price/Earnings (PE) ratio of EQUASENS (EQS.PA)?

The PE ratio for EQUASENS (EQS.PA) is 20.96. This is based on the reported non-GAAP earnings per share of 2.39 and the current share price of 50.1 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EQS.PA.


EQS.PA Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to EQS.PA. When comparing the yearly performance of all stocks, EQS.PA is one of the better performing stocks in the market, outperforming 80.26% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

EQS.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to EQS.PA. EQS.PA gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EQS.PA Financial Highlights

Over the last trailing twelve months EQS.PA reported a non-GAAP Earnings per Share(EPS) of 2.39. The EPS decreased by -23.02% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.72%
ROA 9.1%
ROE 15.65%
Debt/Equity 0.12
Chartmill High Growth Momentum
EPS Q2Q%-24.02%
Sales Q2Q%1.49%
EPS 1Y (TTM)-23.02%
Revenue 1Y (TTM)-1.37%

EQS.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 77% to EQS.PA. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of 27.31% and a revenue growth 9.26% for EQS.PA


Ownership
Inst Owners13.44%
Ins Owners0.2%
Short Float %N/A
Short RatioN/A
Analysts
Analysts76.67
Price Target60.69 (21.14%)
EPS Next Y27.31%
Revenue Next Year9.26%